Monograph Capital

Monograph Capital

London, Englandmonograph.bio

Overview

Monograph Capital is a venture firm focused on life sciences. With a dedicated emphasis on the life sciences sector, Monograph Capital invests in innovative companies and technologies that aim to advance healthcare and biotechnology. The firm supports early-stage ventures as well as growth-stage companies, providing critical capital, strategic guidance, and industry expertise to drive their development and success . Monograph Capital's investments span across biotech, pharmaceuticals, medical devices, and other areas within the life sciences field, aiming to contribute to breakthrough discoveries, therapies, and medical advancements . Through its strategic investments, Monograph Capital plays a crucial role in accelerating innovation and improving health outcomes globally .

Year Founded

2021

Portfolio Companies

16

Investments

CompanyDateStageLead
Nocion TherapeuticsJan 2026Series B ExtensionLead
ProLynx Inc.Dec 2025Series ALead
Elevara MedicinesOct 2025Series ACo-investor
Ollin Biosciences, Inc.Sep 2025Series ALead
Maxion TherapeuticsMar 2025Series ACo-investor

Key People

Charles Conn

Co-founder And Partner, Monograph Capital

Jo T.

EA To Founder And Partner (Start Up Life Science VC)

Tim Funnell

Partner

Bonnie van Wilgenburg

Principal

Freddie Dear

Principal

Jaideep Dudani

Principal

Charlie Zhou

Investment Manager

Melisa Guven

Investment Manager

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.